Report : South America Cardiac Monitoring Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Cardiovascular Devices, Multi-Parameter ECG Monitors, Patient Monitoring Devices, Ambulatory Cardiac Monitoring, and Cardiac Monitors), Product Type (Portable Monitor, Smart Wearable Monitor, and Standard Monitor), Application [Coronary Heart Diseases, Sudden Cardiac Arrest, Stroke, Arrhythmia, Congenital Heart Diseases, Heart Failure, Pulmonary Hypertension, Heart Function (HF/LVEDP), Pulmonary Artery Pressure (PA), and Others], and End User (Hospitals, Ambulatory Surgery Centers, Cardiac Centers, Home Care, Clinics, and Others)
Standard Monitor Segment to Dominate SAM Cardiac Monitoring Devices Market during 2020–2028
According to a new market research study on “SAM Cardiac Monitoring Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Product Type, Application, and End-User” is expected to reach US$ 2,616.31 million by 2028 from 1,782.47 US$ million in 2021. The market is estimated to grow at a CAGR of 5.6% from 2021 to 2028. The report provides trends prevailing in the SAM cardiac monitoring devices market along with the drivers and restraints pertaining to the market growth. Ongoing market consolidations is the major factor driving the growth of the SAM cardiac monitoring devices market. However, issues such as risk of associated cybersecurity vulnerabilities hinders the growth of SAM cardiac monitoring devices market.
The SAM cardiac monitoring devices market is segmented on the basis of type, product type, application, end user, and country. Based on type, the market is segmented into cardiovascular devices, multi-parameter ECG monitors, patient monitoring devices, ambulatory cardiac monitoring, and cardiac monitors. In 2020, the cardiovascular devices segment held the largest share of the market. Based on product type, the SAM cardiac monitoring devices market is segmented into portable monitor, smart wearable monitor, and standard monitor. In 2020, the standard monitor segment held the largest share of the market. Based on application, the market is segmented into coronary heart diseases, sudden cardiac arrest, stroke, arrhythmia, congenital heart diseases, heart failure, pulmonary hypertension, heart function (HF/LVEDP), pulmonary artery pressure (PA), and others. The coronary heart diseases segment held the largest market share in 2020 and is expected to be the largest shareholder in the market by 2028. Based on end user, the SAM cardiac monitoring devices market is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics. The hospitals segment held the largest market share in 2020. Based on country, the SAM cardiac monitoring devices market is segmented into Brazil, Argentina, and the Rest of SAM.
Abbott; AliveCor, Inc; Amiitalia; Asahi Kasei Corporation; Biotronik, Inc.; Boston Scientific Corporation; BTL; GE Healthcare; Hill-Rom Holdings, Inc.; Infinium Medical; Koninklijke Philips N.V.; LivaNova PLC; Medtronic; Nihon Kohden Corporation; MicroPort Scientific Corporation; SCHILLER Healthcare India Pvt. Ltd; and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are among the leading companies in the SAM cardiac monitoring devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: email@example.com